ZINFORO® has proven clinical efficacy across 6 Phase III, randomised, controlled, double-blind trials in adult patients with CAP and cSSTI.1-6
In the FOCUS 1 and FOCUS 2 studies, ZINFORO® was as effective as ceftriaxone in adult patients with CAP4:
Header | ||
---|---|---|
Header | Header | Header |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
The efficacy of ZINFORO® (ceftaroline fosamil) was confirmed in patients with CAP in a real-world setting.
Clinical success in selected subgroups of the CAPTURE study7,8,*
High rates of overall clinical success were observed across various real-world patient subgroups.7,8,*
*CAPTURE was a retrospective cohort study relating to the current treatment practice in the United States. In CAPTURE, ‘clinical success’ was defined as a clinical cure with no further need for antibiotic therapy or clinical improvement with a switch to oral agents at the end of ZINFORO® (ceftaroline fosamil) treatment. As CAPTURE is a retrospective chart review study, it has the limitations inherent to this study design.7,8
CAP, community-acquired pneumonia; CAPTURE, Clinical Assessment Program and Teflaro® Utilization Registry; CE, clinically evaluable; CI, confidence interval; cSSTI, complicated skin and soft tissue infection; MITTE, modified intent-to-treat efficacy; q12h, every 12 hours; q24h, every 24 hours.
References:
Fifth-generation cephalosporin with broad coverage
Simple dosing with a flexible infusion time
Safety profile consistent with other cephalosporins
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered Medical Practitioner*, please visit
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.